Elion Raises $9.3M for Healthcare AI Research and Intelligence Platform
Backed by NEA, Cedars Sinai Health Ventures, and Other Leading Investors, Elion is Building the Go-To Platform to Help Health…
Switching From Reference Adalimumab to Biosimilar Shows No Major Differences in Patients With RA, PsA
Biosimilars can be a more affordable and accessible treatment option for patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA).
Walmart posts 50% leap in US store-fulfilled delivery sales
The jump comes as the retailer’s fast shipping capabilities are driving repeat purchases, CFO John David Rainey said.
Canada Post: ‘Substantial’ gap in contract talks as volume craters
Pay and weekend deliveries remain sticking points in negotiations with the Canadian Union of Postal Workers, and the uncertainty has…
Shaping the Future of mCRC: What Matters, What’s Next, and What to Watch
Panelists discuss how future research in refractory metastatic colorectal cancer must prioritize patient-centered approaches by incorporating patient advocates to understand…
Guidelines vs. Real Life in mCRC: Success Isn’t ‘One Size Fits All’
Panelists discuss how endpoint prioritization in late-line metastatic colorectal cancer therapy differs between providers and patients, with pharmacists focusing primarily…
Optimizing Patient Treatment Adherence in CML
A panelist discusses how pharmacists can significantly improve treatment adherence in chronic myeloid leukemia patients through regular patient touchpoints, adherence…
Taiwan smartphone market gains momentum from new product launches in July
Despite challenges such as high market penetration, extended replacement cycles, tariffs, and inflation, Taiwan’s smartphone market saw July shipments rebound…
South Korea’s industrial giants eye SMR solutions for energy security
During his visit to South Korea, Microsoft founder Bill Gates met with President Lee Jae-myung and SK Group chairman Chey…
US weighs equity stakes in chipmakers under CHIPS Act, but Nvidia off the table
The Trump administration’s move to take a 10% stake in Intel has intensified debate over whether CHIPS and Science Act…